美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Synergy Pharmaceuticals

0.0300

0.0000

成交量：- -

成交額：- -

市值：744.11萬

市盈率：-0.05

高：0.0300

開：0.0300

低：0.0300

收：0.0300

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Synergy Pharmaceuticals

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.synergypharma.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Synergy Pharmaceuticals Inc.於2005年11月15日在佛羅里達州註冊成立，是一家生物製藥公司，主要集中於藥物來治療胃腸道的障礙和疾病的發展。公司主導候選產品是首款治療女性慢性便秘口服藥（plecanatide），一個一種鳥苷酸環化酶C(GC-C)受體激動劑，用於治療胃腸道疾病，主要是慢性特發性便秘，或慢性特發性便秘和便秘型腸易激綜合征，或腸易激綜合征-C。慢性特發性便秘和腸易激綜合征-C是折磨全世界數百萬患者的功能性胃腸病。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SGYP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGYP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGYP\",,,,,undefined,":{"symbol":"SGYP","market":"US","secType":"STK","nameCN":"Synergy Pharmaceuticals","latestPrice":0.03,"timestamp":1552680000000,"preClose":0.03,"halted":0,"volume":0,"delay":0,"floatShares":247204738,"shares":248037301,"eps":-0.561684,"marketStatus":"盤後交易","change":0,"latestTime":"05-13 17:43:53 EDT","open":0.03,"high":0.03,"low":0.03,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.561684,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1747180800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.03,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGYP\",,,,,undefined,":{"symbol":"SGYP","floatShares":247204738,"roa":"--","roe":"--","lyrEps":-0.995115,"shares":248037301,"dividePrice":0,"high":0.03,"amplitude":0,"preClose":0.03,"low":0.03,"week52Low":0.03,"pbRate":"-0.08","week52High":2.235,"institutionHeld":0,"latestPrice":0.03,"eps":-0.561684,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.561684,"open":0.03,"prevYearClose":0.03},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.synergypharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0346},{"period":"1month","weight":0.0919},{"period":"3month","weight":-0.0369},{"period":"6month","weight":-0.0238},{"period":"1year","weight":0.1193},{"period":"ytd","weight":-0.0053}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Synergy Pharmaceuticals Inc.於2005年11月15日在佛羅里達州註冊成立，是一家生物製藥公司，主要集中於藥物來治療胃腸道的障礙和疾病的發展。公司主導候選產品是首款治療女性慢性便秘口服藥（plecanatide），一個一種鳥苷酸環化酶C(GC-C)受體激動劑，用於治療胃腸道疾病，主要是慢性特發性便秘，或慢性特發性便秘和便秘型腸易激綜合征，或腸易激綜合征-C。慢性特發性便秘和腸易激綜合征-C是折磨全世界數百萬患者的功能性胃腸病。","exchange":"NASDAQ","name":"Synergy Pharmaceuticals","nameEN":"Synergy Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SGYP\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGYP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"SGYP","fiscalQuarterEnding":"2018/09","expectedEps":-0.13,"name":null,"time":"盤後","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2018-08-07","symbol":"SGYP","fiscalQuarterEnding":"2018/06","expectedEps":-0.17,"name":null,"time":"","type":"earning","dateTimestamp":1533614400000,"reportTimeType":"","actualEps":-0.12},{"market":"US","date":"2018-05-10","symbol":"SGYP","fiscalQuarterEnding":"2018/03","expectedEps":-0.17,"name":null,"time":"盤後","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2018-03-01","symbol":"SGYP","fiscalQuarterEnding":"2017/12","expectedEps":-0.19,"name":null,"time":"盤後","type":"earning","dateTimestamp":1519880400000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2017-11-09","symbol":"SGYP","fiscalQuarterEnding":"2017/09","expectedEps":-0.27,"name":null,"time":"盤後","type":"earning","dateTimestamp":1510203600000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGYP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGYP\",market:\"US\",delay:false,,,undefined,":{}}}